What Researchers Did
Researchers reported on a 70-year-old male with central retinal artery occlusion (CRAO) who received hyperbaric oxygen therapy (HBOT) within 48 hours of symptom onset.
What They Found
A 70-year-old male presented with painless vision loss in his right eye, with initial light perception. Hyperbaric oxygen therapy (HBOT) was initiated within 48 hours of presentation, leading to an improvement in vision where light perception expanded beyond the peripheral area after the first treatment.
What This Means for Canadian Patients
For Canadian patients experiencing central retinal artery occlusion (CRAO), this case suggests that hyperbaric oxygen therapy (HBOT) might offer a potential treatment option, even when initiated beyond the conventional 6-12 hour window. While not a cure, it indicates that some visual improvement, such as expanded light perception, could be possible in delayed presentations.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a single case report, this study's findings are limited in generalizability and cannot establish definitive treatment efficacy.